HomeNewsWorldQuad's commitment to provide a billion vaccines to people in Southeast Asia is on track: White House official

Quad's commitment to provide a billion vaccines to people in Southeast Asia is on track: White House official

In March, leaders of the Quad -- comprising Australia, India, Japan and the United States –during a virtual summit had committed themselves to provide a billion vaccines to Southeast Asia.

June 09, 2021 / 07:43 IST
Story continues below Advertisement
The ‘Quad initiative’ as it is dubbed – will fund vaccine production in the Indo-Pacific region and the two key meetings held in May were in regards to “modalities for funding” (Image Source: Shutterstock)
The ‘Quad initiative’ as it is dubbed – will fund vaccine production in the Indo-Pacific region and the two key meetings held in May were in regards to “modalities for funding” (Image Source: Shutterstock)

The commitment of the Quad nations to provide a billion Covid vaccines to people in Southeast Asia by 2022 is still on track, despite a devastating second wave of the coronavirus pandemic in India, a top White House official has said.

In March, leaders of the Quad -- comprising Australia, India, Japan and the United States –during a virtual summit had committed themselves to provide a billion vaccines to Southeast Asia.

Story continues below Advertisement

These vaccines were to be manufactured in India, but due to the second wave of the COVID-19 pandemic certain quarters are raising doubts if the Quad can meet its commitment by 2022.

"We have been in close consultations with our partners and with India. Obviously, this is an extremely difficult period for Indian friends. The United States has tried to stand with Delhi and to bring others both in the private and the public sectors to support them," Kurt Campbell, the White House''s Indo-Pacific policy director, said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show